GlassScriptPhysician profile
Vijaykumar N Patel
NPI 1295703866
$900.11
in general payments reported to CMS, 2019-2025
20 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $102 · 2021: $101 · 2022: $89.20 · 2023: $84.72 · 2024: $188 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $128.60 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $100.10 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.94 | 2025 | Lifevest |
| Glaxosmithkline, LLC. | $83.19 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $82.55 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $74.07 | 2021-2024 | Breztri, Seroquel |
| Amarin Pharma, INC. | $51.19 | 2019-2021 | |
| Grifols USA, LLC | $49.61 | 2022-2025 | Prolastin-C Liquid |
| Shield Therapeutics INC | $39.06 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $29.17 | 2020-2021 | |
| Chiesi USA, INC. | $25.19 | 2025 | Kengreal |
| Shire North American Group INC | $22.85 | 2019 | |
| Abbott Laboratories | $18.55 | 2022 | |
| Amgen INC. | $17.91 | 2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.34 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.59 | 2024 | Zepbound |
| Novo Nordisk INC | $14.41 | 2023 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.63 | 2020 | |
| Allergan, INC. | $13.42 | 2020 | |
| Tersera Therapeutics LLC | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijaykumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.